The company in question is, Medivation, Inc. (NASDAQ:MDVN) currently with a stock price of 62.9 (0.58% today). The market cap for Medivation, Inc. is 10272.2, and is in the sector Healthcare, and Biotechnology industry. The target price for Medivation, Inc. is 64.65. Currently Medivation, Inc. is trading with a P/E of 43.73, and a forward P/E of 28.06. Average volume for Medivation, Inc. is 2772.75 and so far today it is 377583.
Performance in the last year for Medivation, Inc. has been 14.06%. For EPS growth, Medivation, Inc. has seen a growth of -11.10%, and is looking to grow in the next year to 72.52%. More long term stats show that EPS growth has been 50.90% over the last five years and could be 35.15% for the next five years. Medivation, Inc. has seen sales growth quarter over quarter at 41.30%, with EPS growth quarter over quarter at 243.60%. The 20-day simple moving average is 3.80%, with the 200-day simple moving average coming to 34.72%.
Since the IPO date for Medivation, Inc. on the 1/13/1997, Medivation, Inc. has seen performance year to date to be 29.38%. With Medivation, Inc. trading at 62.9, the dividend yield is *TBA, and the EPS is 1.43.
So could Medivation, Inc., be undervalued? Well as said before P/E is 43.73. The PEG is 1.24, P/S is 10.31 and the P/B is at 11.41. The P/cash is *TBA, with P/free cash flow at 34.17.
Medivation, Inc. ability to deal with debt shows that the current ratio is 4.2, and the quick ratio is 4.2. This is with long term debt/equity at 0, and total debt/equity at 0.
In terms of margins, Medivation, Inc. has a gross margin of *TBA, an operating margin of 40.20% and a profit margin of 25.40%.Payout ratio for Medivation, Inc. is 0.00%. Return on assets come to 21.50% with return on investment coming to 27.10%.
Insider ownership for Medivation, Inc., is at 1.20% and institutional ownership comes to 92.80%. Outstanding shares are at 164.25. While shares float is 162.47. The float short is currently 1.97%, and short ratio is 1.15.